Key Points
- Doximity director Kira Wampler sold 2,000 shares for approximately $57,820, reducing her direct holdings by 6.68% to 27,923 shares. The transaction occurred under a pre-arranged Rule 10b5-1 trading plan.
- Doximity reported quarterly EPS of $0.29, exceeding the $0.16 analyst consensus, while revenue rose 7.3% year over year to $156.62 million. The company posted a 25.48% net margin and 18.06% return on equity.
- Analyst sentiment remains mixed, with a consensus “Hold” rating and a $31.95 price target; 14 analysts rate the stock Hold, while seven rate it Buy and three rate it Sell.
Doximity, Inc. (NYSE:DOCS - Get Free Report) Director Kira Wampler sold 2,000 shares of the stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $28.91, for a total value of $57,820.00. Following the completion of the transaction, the director directly owned 27,923 shares in the company, valued at approximately $807,253.93. This represents a 6.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Kira Scherer Wampler also recently made the following trade(s):
- On Tuesday, August 25th, Kira Wampler sold 2,000 shares of Doximity stock. The shares were sold at an average price of $24.95, for a total value of $49,900.00.
Doximity Stock Up 2.7%
NYSE DOCS opened at $28.69 on Tuesday. The company has a 50-day moving average price of $25.35 and a 200-day moving average price of $23.28. Doximity, Inc. has a 52 week low of $17.15 and a 52 week high of $73.92. The firm has a market capitalization of $5.11 billion, a P/E ratio of 33.75, a PEG ratio of 21.85 and a beta of 1.22.
Doximity (NYSE:DOCS - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.16 by $0.13. The company had revenue of $156.62 million for the quarter. Doximity had a net margin of 25.48% and a return on equity of 18.06%. The business's quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.36 EPS. As a group, equities research analysts anticipate that Doximity, Inc. will post 0.74 EPS for the current year.
Analysts Set New Price Targets
Several research firms have recently commented on DOCS. Weiss Ratings upgraded Doximity from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Monday, September 14th. Wells Fargo & Company lowered Doximity from an "equal weight" rating to an "underweight" rating and set a $18.00 price target for the company. in a report on Monday, August 10th. Bank of America restated an "underperform" rating and issued a $20.00 price target (down from $38.00) on shares of Doximity in a research report on Monday, June 29th. Piper Sandler reaffirmed an "overweight" rating and issued a $47.00 price objective (up from $42.00) on shares of Doximity in a research note on Friday, August 7th. Finally, Stifel Nicolaus set a $27.00 price objective on Doximity in a research report on Tuesday, September 8th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $31.95.
Read Our Latest Research Report on DOCS
More Doximity News
Here are the key news stories impacting Doximity this week:
- Positive Sentiment: Analyst commentary highlighted Doximity’s rapid clinical AI adoption, strong cash generation and longer-term portfolio appeal. The company may benefit from expanding AI use among healthcare professionals, though tight pharmaceutical budgets and rising AI-related costs could limit near-term gains. Reasons to Retain Doximity Stock in Your Portfolio for Now
- Positive Sentiment: Doximity outperformed the broader market in the latest trading session, indicating that investors were willing to look past the legal headlines and focus on the company’s operating outlook. Doximity Surpasses Market Returns
- Neutral Sentiment: Director Kira Wampler sold 2,000 shares worth approximately $57,820 under a pre-arranged Rule 10b5-1 trading plan. The sale reduced her position by 6.68%, but its planned nature makes it a less significant signal of insider sentiment. SEC Insider Transaction Filing
- Negative Sentiment: Several law firms publicized a securities-fraud class action involving investors who purchased Doximity shares from August 8, 2024, through May 13, 2026. The allegations concern purported misrepresentations about Newsfeed revenue growth and the use of “light engagement” advertising formats. Investors have until November 16, 2026, to seek lead-plaintiff status; the allegations have not been proven. Doximity Securities Class Action Notice
Institutional Trading of Doximity
Several institutional investors and hedge funds have recently modified their holdings of the company. Leonteq Securities AG boosted its holdings in Doximity by 65.6% in the first quarter. Leonteq Securities AG now owns 2,912 shares of the company's stock worth $68,000 after acquiring an additional 1,154 shares in the last quarter. Pictet Asset Management Holding SA increased its holdings in shares of Doximity by 6.4% during the first quarter. Pictet Asset Management Holding SA now owns 19,224 shares of the company's stock valued at $448,000 after acquiring an additional 1,156 shares in the last quarter. Parallel Advisors LLC increased its holdings in shares of Doximity by 111.0% during the first quarter. Parallel Advisors LLC now owns 2,560 shares of the company's stock valued at $60,000 after acquiring an additional 1,347 shares in the last quarter. Versant Capital Management Inc raised its position in shares of Doximity by 1,176.9% in the 3rd quarter. Versant Capital Management Inc now owns 1,826 shares of the company's stock valued at $52,000 after purchasing an additional 1,683 shares during the last quarter. Finally, Central Pacific Bank Trust Division boosted its stake in Doximity by 34.3% in the 2nd quarter. Central Pacific Bank Trust Division now owns 6,972 shares of the company's stock worth $145,000 after purchasing an additional 1,780 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.
About Doximity
(
Get Free Report)
Doximity, Inc operates a digital platform designed for U.S. medical professionals. Its network enables physicians, nurse practitioners, physician assistants and other healthcare providers to connect with colleagues, exchange clinical information and access professional resources.
The company offers tools for telehealth and care coordination, including video and phone-based communication services, as well as digital faxing and secure messaging capabilities. Doximity also provides medical news and research content tailored to healthcare professionals.
Doximity generates additional business through recruiting and marketing solutions that help healthcare organizations reach clinicians and promote employment opportunities, services and products.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
